carbidopa; levodopa · Avion Pharms · NDA 214869
Dhivy
Earliest generic entry, as listed
28 Mar 2039
Blocked by patent: US 11033521, US 11439613, US 11819485.
Listed patents · 3 unexpired
5 Orange Book listing rows for 3 patents. FDA lists a patent once for each use code, and lists its pediatric extension as a separate row.
| Patent | Claims | Expires |
|---|---|---|
| US 11033521 | drug product, use U-219, U-3304, U-3305 | 28 Mar 2039 |
| US 11033521 listing row | drug product, use U-219 · sets the listed date | 28 Mar 2039 |
| US 11033521 listing row | drug product, use U-3304 · sets the listed date | 28 Mar 2039 |
| US 11033521 listing row | drug product, use U-3305 · sets the listed date | 28 Mar 2039 |
| US 11439613 | use U-3557 · sets the listed date | 28 Mar 2039 |
| US 11819485 | use U-3557 · sets the listed date | 28 Mar 2039 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 214869 · 001 · RLD | tablet, oral | 25MG;100MG | 28 Mar 2039 |